Tag: chronic lymphocytic leukemia

Adding pirtobrutinib to venetoclax-rituximab improves survival in relapsed chronic lymphocytic leukemia

Adding the BTK inhibitor pirtobrutinib to venetoclax-rituximab significantly improves progression-free survival in patients with relapsed or refractory chronic lymphocytic leukemia,…